Metrics to compare | SINT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSINTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | 7.7x | −0.3x | |
PEG Ratio | −0.01 | 0.05 | 0.00 | |
Price/Book | 2.2x | 2.3x | 2.6x | |
Price / LTM Sales | 7.9x | 1.9x | 2.9x | |
Upside (Analyst Target) | - | 174.3% | 65.5% | |
Fair Value Upside | Unlock | 30.6% | 9.5% | Unlock |
Sintx Technologies, Inc., an advanced ceramics and biomaterials company, engages in the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). It also provides insulators for Tier 1 aerospace suppliers; SiNAPTIC® Foot & Ankle Osteotomy Wedge System for reconstructive surgery; OEM manufacturing of spinal implants; and SiNERGY™ technology platform for bio composite and 3D printing applications. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.